A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group, Am J Cardiol, vol.84, pp.46-50, 1999. ,
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial, Jama, vol.291, pp.309-325, 2004. ,
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions, Circulation, vol.113, pp.2462-72, 2006. ,
Ranolazine, a novel agent for chronic stable angina, Pharmacotherapy, vol.26, pp.135-177, 2006. ,
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties, Circulation, vol.110, pp.904-914, 2004. ,
Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes, J Cardiovasc Pharmacol, vol.44, pp.192-201, 2004. ,
Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action, Br J Pharmacol, vol.148, pp.16-24, 2006. ,
Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current, J Cardiovasc Electrophysiol, vol.17, issue.1, pp.169-177, 2006. ,
The cardiac persistent sodium current: an appealing therapeutic target?, Br J Pharmacol, vol.153, pp.1133-1175, 2008. ,
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts, J Mol Cell Cardiol, vol.41, pp.1031-1039, 2006. ,
Mechanism of action of the new anti-ischemia drug ranolazine, Clin Res Cardiol, vol.97, pp.222-228, 2008. ,
New drugs vs. old concepts: a fresh look at antiarrhythmics, Pharmacol Ther, vol.132, pp.125-170, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01822221
Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide, J Clin Invest, vol.99, pp.185-93, 1997. ,
, Scientific RepoRts |, vol.5
Voltage-gated sodium channels in human aortic smooth muscle cells, J Vasc Res, vol.35, pp.310-317, 1998. ,
Evidence for tetrodotoxin-sensitive sodium currents in primary cultured myocytes from human, pig and rabbit arteries, Pflugers Arch, vol.440, pp.149-52, 2000. ,
TTX-sensitive voltage-gated Na+ channels are expressed in mesenteric artery smooth muscle cells, Am J Physiol Heart Circ Physiol, vol.289, pp.137-182, 2005. ,
Regulation of Ca2+ homeostasis by atypical Na+ currents in cultured human coronary myocytes, Circ Res, vol.85, pp.606-619, 1999. ,
New insights in the contribution of voltage-gated Na(v) channels to rat aorta contraction, PLoS One, vol.4, p.7360, 2009. ,
Effective contractile response to voltage-gated Na(+ ) channels revealed by a channel activator, Am J Physiol Cell Physiol, vol.304, pp.739-786, 2013. ,
The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease, J Am Coll Cardiol, vol.56, pp.934-976, 2010. ,
Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine, J Cardiovasc Pharmacol, vol.21, pp.869-73, 1993. ,
Ranolazine injection into coronary or femoral arteries exerts marked, transient regional vasodilation without systemic hypotension in an intact porcine model, Circ Cardiovasc Interv, vol.4, pp.481-488, 2011. ,
Effects of Ranolazine on Vasomotor Responses of Rat Aortic Rings, Arch Med Res, 2012. ,
Effect of ranolazine on rat intrarenal arteries in vitro, Eur J Pharmacol, vol.683, pp.211-217, 2012. ,
Ranolazine enhances nicardipine-induced relaxation of alpha1-adrenoceptor-mediated contraction on isolated rabbit aorta, Acta Cardiol, vol.70, pp.157-62, 2015. ,
Forefront of Na+ /Ca2+ exchanger studies: molecular pharmacology of Na+ /Ca2+ exchange inhibitors, J Pharmacol Sci, vol.96, pp.27-32, 2004. ,
Role of ranolazine in angina, heart failure, arrhythmias, and diabetes, Pharmacol Ther, vol.133, pp.311-334, 2012. ,
Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins, Cell Signal, vol.15, pp.151-160, 2003. ,
The paradox of alpha-adrenergic coronary vasoconstriction revisited, J Mol Cell Cardiol, vol.51, pp.16-23, 2011. ,
State-and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine, Mol Pharmacol, vol.73, pp.940-948, 2008. ,
Electrophysiologic basis for the antiarrhythmic actions of ranolazine, Heart Rhythm, vol.8, pp.1281-90, 2011. ,
Vasorelaxant effect of ranolazine on isolated normal and diabetic rat aorta: A study of possible mechanisms, Acta Physiol Hung, vol.100, pp.153-62, 2013. ,
Effects of yohimbine stereoisomers on contractions of rat aortic strips produced by agonists with different selectivity for alpha 1-and alpha 2-adrenoceptors, Eur J Pharmacol, vol.96, pp.95-104, 1983. ,
Effects of voltage-gated Na+ channel toxins from Tityus serrulatus venom on rat arterial blood pressure and plasma catecholamines, Comp Biochem Physiol C Toxicol Pharmacol, vol.141, pp.85-92, 2005. ,
Local and neurohumoral control of coronary blood flow, Basic Res Cardiol, vol.88, issue.1, pp.25-42, 1993. ,
Role of adrenergic receptors in human coronary vasomotion, Heart, vol.95, pp.603-611, 2009. ,
Late sodium current inhibition as a new cardioprotective approach, J Mol Cell Cardiol, vol.44, pp.954-67, 2008. ,
Antiarrhythmic properties of ranolazine-from bench to bedside, Expert Opin Investig Drugs, vol.21, pp.1733-1774, 2012. ,
The late Na current as a therapeutic target: Where are we?, J Mol Cell Cardiol, vol.61, pp.44-50, 2013. ,
F 15845, a new blocker of the persistent sodium current prevents consequences of hypoxia in rat femoral artery, Br J Pharmacol, vol.161, pp.405-420, 2010. ,
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries, Circulation, vol.99, pp.2090-2097, 1999. ,
Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries, J Am Coll Cardiol, vol.33, pp.1499-505, 1999. ,
A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images, JACC Cardiovasc Imaging, vol.2, pp.1301-1310, 2009. ,
Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease, Am J Cardiol, vol.110, pp.1440-1445, 2012. ,
Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials, J Cardiovasc Pharmacol Ther, vol.9, issue.1, pp.47-64, 2004. ,
Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and metaanalysis, Int J Cardiol, vol.169, pp.262-70, 2013. ,
Alpha 1 adrenoreceptor antagonists, J Clin Hypertens (Greenwich), vol.13, pp.654-661, 2011. ,
Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery, Acta Physiol Scand, vol.173, pp.257-65, 2001. ,
Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart, Am J Physiol, vol.277, pp.2458-69, 1999. ,
Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway, Br J Pharmacol, vol.161, pp.799-814, 2010. ,
The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes, Br J Pharmacol, vol.158, pp.209-233, 2009. ,